ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息（分红）
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
Spherix, Inc.
1.63
0.0000
成交量：
- -
成交額：
- -
市值：
2,245.10萬
市盈率：
-0.83
高：
1.63
開：
1.63
低：
1.63
收：
1.63
資料載入中...
總覽
公司
新聞
公告
2021/06/10
重要事件披露
8-K - Current report
2021/05/13
重要事件披露
8-K - Current report
2021/05/10
季度報告
10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/03
重要事件披露
8-K - Current report
2021/04/16
重要事件披露
8-K - Current report
2021/04/13
重要事件披露
8-K - Current report
2021/03/25
年度報告
10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/05
重要事件披露
8-K - Current report
2021/02/25
超過5%披露
SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/25
超過5%披露
SC 13D - General statement of acquisition of beneficial ownership
2021/02/18
重要事件披露
8-K - Current report
2021/02/17
超過5%披露
SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16
超過5%披露
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03
重要事件披露
8-K - Current report
2021/01/25
重要事件披露
8-K - Current report
2021/01/19
重要事件披露
8-K - Current report
2021/01/11
重要事件披露
8-K - Current report
2021/01/05
超過5%披露
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/20
重要事件披露
8-K - Current report
2020/11/13
季度報告
10-Q - Quarterly report [Sections 13 or 15(d)]
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SPEX/filings"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPEX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPEX\",,,,,undefined,":{"symbol":"SPEX","market":"US","secType":"STK","nameCN":"Spherix, Inc.","latestPrice":1.63,"timestamp":1584043200000,"preClose":1.63,"halted":8,"volume":0,"delay":0,"floatShares":4136026,"shares":13773600,"eps":-1.97,"marketStatus":"休市中","change":0,"latestTime":"03-12 16:00:00 EDT","open":1.63,"high":1.63,"low":1.63,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.97,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1747641600000},"marketStatusCode":7,"symbolChange":{"newSymbol":"AIKI","executeDate":"2020-03-13"},"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.63,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPEX\",,,,,undefined,":{"symbol":"SPEX","floatShares":4136026,"roa":"-28.97%","roe":"-36.97%","lyrEps":-1.665494,"shares":13773600,"dividePrice":0,"high":1.63,"amplitude":0,"preClose":1.63,"low":1.63,"week52Low":0.65,"pbRate":"2.13","week52High":5.52,"institutionHeld":0.0903,"latestPrice":1.63,"eps":-1.97,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.97,"open":1.63},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"SPEX\",pageSize:20,pageCount:1,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"12883629","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021031800-SPEX","pdf_url":null,"pub_time":1623254400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/0001213900-21-031800-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AIKI 2021 LD MICRO INVITATIONAL XI PRESENTATION DECK, DATED JUNE 10, 2021","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ea142513ex99-1_aikido.htm","primary":true,"translateUrl":null,"linkName":"ea142513ex99-1_aikido.htm","type":"EX-99.1","id":"NTFILE3oo2mF76gv6eNi5y","market":"us","size":19266},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ea142513-8k_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea142513-8k_aikidopharma.htm","type":"8-K","id":"NTFILE5u8WsQGXEuaFRAD8","market":"us","size":29068},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEEaaguf4zqvnSZaQr","market":"us","size":74902},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_002.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_002.jpg","type":"GRAPHIC","id":"NTFILEEEGb16VLahn44RkA","market":"us","size":181200},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_003.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_003.jpg","type":"GRAPHIC","id":"NTFILEDAkSeW2Ya2eCK5YA","market":"us","size":138834},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_004.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_004.jpg","type":"GRAPHIC","id":"NTFILEDq3eA5osx9xoreKF","market":"us","size":179332},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_005.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_005.jpg","type":"GRAPHIC","id":"NTFILEAeLZM8Fn2TSfdGKS","market":"us","size":217409},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_006.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_006.jpg","type":"GRAPHIC","id":"NTFILE65szotZqaUxHDvsh","market":"us","size":225046},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_007.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_007.jpg","type":"GRAPHIC","id":"NTFILE7yxMqkQU2wx3rneC","market":"us","size":156611},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_008.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_008.jpg","type":"GRAPHIC","id":"NTFILE9ZFv4evqs2hbJSde","market":"us","size":189506},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_009.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_009.jpg","type":"GRAPHIC","id":"NTFILE3Fu8yysFN6kfvikB","market":"us","size":224152},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_010.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_010.jpg","type":"GRAPHIC","id":"NTFILEBtvHCYutUhjvfSs1","market":"us","size":181544},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_011.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_011.jpg","type":"GRAPHIC","id":"NTFILEGqb9Ge58sM4F7sqt","market":"us","size":221810},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_012.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_012.jpg","type":"GRAPHIC","id":"NTFILE9WrVaR6htJTio85U","market":"us","size":193360},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_013.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_013.jpg","type":"GRAPHIC","id":"NTFILE3m31WrmUMTBMPXYW","market":"us","size":188517},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_014.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_014.jpg","type":"GRAPHIC","id":"NTFILEBrBXnXQTPqP1x6qT","market":"us","size":71313}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-06-10 00:00","pubTimestamp":1623254400,"title_zh":"8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"項目8.01：其他項目；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883624","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021025950-SPEX","pdf_url":null,"pub_time":1620835200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/0001213900-21-025950-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"BENZINGA GLOBAL SMALL CAP CONFERENCE PRESENTATION, DATED MAY 13, 2021","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ea140763ex99-1_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"ea140763ex99-1_aikidopharma.htm","type":"EX-99.1","id":"NTFILEvXazQCuxLLyWDsgr","market":"us","size":15316},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ea140763-8k_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea140763-8k_aikidopharma.htm","type":"8-K","id":"NTFILEDpASpEWEbV7AZbq6","market":"us","size":19340},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE6DmmgsRd1vH2MgRX","market":"us","size":101978},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_002.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_002.jpg","type":"GRAPHIC","id":"NTFILE27JBAUL45Asd5zPJ","market":"us","size":251316},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_003.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_003.jpg","type":"GRAPHIC","id":"NTFILE7TYsZ32i4XgwKJHi","market":"us","size":200762},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_004.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_004.jpg","type":"GRAPHIC","id":"NTFILE9aSzqY1drfoKEUS5","market":"us","size":245231},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_005.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_005.jpg","type":"GRAPHIC","id":"NTFILE79Kyg4s6t7E4BCZk","market":"us","size":284116},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_006.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_006.jpg","type":"GRAPHIC","id":"NTFILE5ad1vp1SEH6Sx5Nk","market":"us","size":211274},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_007.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_007.jpg","type":"GRAPHIC","id":"NTFILEHy6DCwQJ2fdGaDVS","market":"us","size":260371},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_008.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_008.jpg","type":"GRAPHIC","id":"NTFILEDLokJ9R216UUrHP9","market":"us","size":249345},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_009.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_009.jpg","type":"GRAPHIC","id":"NTFILEAwGjkEQt4oogrTxQ","market":"us","size":304202},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_010.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_010.jpg","type":"GRAPHIC","id":"NTFILEAxCW9uqRtEAyYg3A","market":"us","size":260499},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_011.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_011.jpg","type":"GRAPHIC","id":"NTFILEBmQGYqXEFy4NjbED","market":"us","size":103852}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-05-13 00:00","pubTimestamp":1620835200,"title_zh":"8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"項目8.01：其他項目；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883602","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021025331-SPEX","pdf_url":null,"pub_time":1620576000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"SPEX","title":"10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度報告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/0001213900-21-025331-index.htm","us_notice_code":"Form 10-Q","us_title_en":"10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":true,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"財務報告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"財務報告","earn_infos":[{"id":98436,"name":"Condensed Consolidated Balance Sheets","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R2.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98437,"name":"Condensed Consolidated Balance Sheets (Parentheticals)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R3.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98438,"name":"Condensed Consolidated Statements of Operations (Unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R4.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98439,"name":"Condensed Consolidated Statements of Changes in Stockholders??? Equity","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R5.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98440,"name":"Condensed Consolidated Statements of Changes in Stockholders??? Equity (Parentheticals)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R6.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98441,"name":"Condensed Consolidated Statements of Cash Flows","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R7.htm","cdn_url":"","translation_url":"","translate_status":0}],"event_type":"important_notice","event_name":"季度報告","pubTime":"2021-05-10 00:00","pubTimestamp":1620576000,"title_zh":"10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883619","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021024121-SPEX","pdf_url":null,"pub_time":1619971200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021024121/0001213900-21-024121-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-05-03 00:00","pubTimestamp":1619971200,"title_zh":"8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"項目8.01：其他項目；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883596","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021021934-SPEX","pdf_url":null,"pub_time":1618502400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021934/0001213900-21-021934-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXCLUSIVE PATENT LICENSE AGREEMENT BY AND AMONG SILO PHARMA INC., A DELAWARE COR","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021934/ea139554ex10-1_alkidipharm.htm","primary":true,"translateUrl":null,"linkName":"ea139554ex10-1_alkidipharm.htm","type":"EX-10.1","id":"NTFILE4rTMbUWpDsziDjSV","market":"us","size":111212},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021934/ea139554-8k_alkidipharm.htm","primary":false,"translateUrl":null,"linkName":"ea139554-8k_alkidipharm.htm","type":"8-K","id":"NTFILE2hpS2YC9cdVn7BpQ","market":"us","size":23674},{"description":"AMENDMENT TO EXCLUSIVE PATENT LICENSE AGREEMENT, DATED APRIL 12, 2021.","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021934/ea139554ex10-2_alkidipharm.htm","primary":false,"translateUrl":null,"linkName":"ea139554ex10-2_alkidipharm.htm","type":"EX-10.2","id":"NTFILEienE3zGfGP5SBtgT","market":"us","size":124955}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-04-16 00:00","pubTimestamp":1618502400,"title_zh":"8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01項：訂立重要最終協議；第5.02項：董事或某些高級職員離任；選舉董事；某些主席團成員的任命：某些主席團成員的補償安排；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883599","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021021415-SPEX","pdf_url":null,"pub_time":1618243200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021415/0001213900-21-021415-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 4.01: Changes in Registrant's Certifying Accountant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"LETTER OF MARCUM LLP, TO THE SECURITIES AND EXCHANGE COMMISSION DATED APRIL 12,","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021415/ea139404ex16-1_aikido.htm","primary":true,"translateUrl":null,"linkName":"ea139404ex16-1_aikido.htm","type":"EX-16.1","id":"NTFILEGeDZsQHK1dHwzkZH","market":"us","size":3189},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021415/ea139404-8k_aikido.htm","primary":false,"translateUrl":null,"linkName":"ea139404-8k_aikido.htm","type":"8-K","id":"NTFILE8viVqbniPXcWyZL6","market":"us","size":21086}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-04-13 00:00","pubTimestamp":1618243200,"title_zh":"8-K - Current report","summary_en":"Item 4.01: Changes in Registrant's Certifying Accountant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第4.01項：註冊人註冊會計師變更；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883621","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021017738-SPEX","pdf_url":null,"pub_time":1616601600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"SPEX","title":"10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"年度報告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/0001213900-21-017738-index.htm","us_notice_code":"Form 10-K","us_title_en":"10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/f10k2020_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"f10k2020_aikidopharma.htm","type":"10-K","id":"NTFILE7BeoeZnyytJVEWqj","market":"us","size":1018017},{"description":"LIST OF SUBSIDIARIES","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/f10k2020ex21-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10k2020ex21-1_aikido.htm","type":"EX-21.1","id":"NTFILEDGoutwNn8rPeCrPy","market":"us","size":2637},{"description":"INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S CONSENT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/f10k2020ex23-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10k2020ex23-1_aikido.htm","type":"EX-23.1","id":"NTFILEAeQ654jz4Aah1j4u","market":"us","size":2073},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/f10k2020ex31-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10k2020ex31-1_aikido.htm","type":"EX-31.1","id":"NTFILE6Yn81V1Axai3C7Mt","market":"us","size":14625},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/f10k2020ex32-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10k2020ex32-1_aikido.htm","type":"EX-32.1","id":"NTFILE8QKjET1csJvVz72T","market":"us","size":7024},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/img_001.jpg","primary":false,"translateUrl":null,"linkName":"img_001.jpg","type":"GRAPHIC","id":"NTFILEELvyBjNhwzrmYMoz","market":"us","size":7209},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/img_002.jpg","primary":false,"translateUrl":null,"linkName":"img_002.jpg","type":"GRAPHIC","id":"NTFILE5K6a19yGpZq6d1Z2","market":"us","size":9017}],"type_name":"財務報告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"財務報告","earn_infos":[],"event_type":"important_notice","event_name":"年度報告","pubTime":"2021-03-25 00:00","pubTimestamp":1616601600,"title_zh":"10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883630","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021013614-SPEX","pdf_url":null,"pub_time":1614873600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/0001213900-21-013614-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"INVESTOR PRESENTATION, DATED MARCH 2021","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ea137036ex99-1_aikidopharm.htm","primary":true,"translateUrl":null,"linkName":"ea137036ex99-1_aikidopharm.htm","type":"EX-99.1","id":"NTFILE4pij9WsJtM44esbd","market":"us","size":20791},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ea137036-8k_aikidopharm.htm","primary":false,"translateUrl":null,"linkName":"ea137036-8k_aikidopharm.htm","type":"8-K","id":"NTFILEDLLHFw31oiAsqxmB","market":"us","size":18837},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE3qMAZntttuiFgLDF","market":"us","size":62678},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_002.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_002.jpg","type":"GRAPHIC","id":"NTFILEDhZ5RZeuZ5ALWSXx","market":"us","size":120946},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_003.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_003.jpg","type":"GRAPHIC","id":"NTFILEGJ63ZggoiHrgNhsG","market":"us","size":138569},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_004.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_004.jpg","type":"GRAPHIC","id":"NTFILE4cYx2QaYGwSScdRz","market":"us","size":167764},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_005.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_005.jpg","type":"GRAPHIC","id":"NTFILECbafdTb67tbKRds3","market":"us","size":149916},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_006.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_006.jpg","type":"GRAPHIC","id":"NTFILEDyUBktFRG2dXu4Gt","market":"us","size":136336},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_007.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_007.jpg","type":"GRAPHIC","id":"NTFILE3dUFr5z9NKhFGG6A","market":"us","size":185503},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_008.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_008.jpg","type":"GRAPHIC","id":"NTFILE4H1gT3XmyM7u3xYT","market":"us","size":115928},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_009.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_009.jpg","type":"GRAPHIC","id":"NTFILE9AT95imrnZfT1FuR","market":"us","size":164385},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_010.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_010.jpg","type":"GRAPHIC","id":"NTFILE9oja1kLyFHGQcdfx","market":"us","size":158676},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_011.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_011.jpg","type":"GRAPHIC","id":"NTFILEHA83cdn2qxrKUKdC","market":"us","size":146019},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_012.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_012.jpg","type":"GRAPHIC","id":"NTFILEGaTcQpwEicj5iYFJ","market":"us","size":161590},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_013.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_013.jpg","type":"GRAPHIC","id":"NTFILE2K7BheZAGKmHNAT7","market":"us","size":106514},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_014.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_014.jpg","type":"GRAPHIC","id":"NTFILEDG3AC6Zmprn32ZrB","market":"us","size":160789},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_015.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_015.jpg","type":"GRAPHIC","id":"NTFILE4qqYRSqCuu2tB4Px","market":"us","size":54726}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-03-05 00:00","pubTimestamp":1614873600,"title_zh":"8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01項：條例FD披露；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883613","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465921027944-SPEX","pdf_url":null,"pub_time":1614182400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G - Statement of acquisition of beneficial ownership by individuals","symbol":"SPEX","title":"SC 13G - Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000110465921027944/0001104659-21-027944-index.htm","us_notice_code":"Form SC 13G","us_title_en":"SC 13G - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SC 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000110465921027944/tm217745d5_sc13g.htm","primary":true,"translateUrl":null,"linkName":"tm217745d5_sc13g.htm","type":"SC 13G","id":"NTFILEEfYjx4WYTo6d3kZi","market":"us","size":67296}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2021-02-25 00:00","pubTimestamp":1614182400,"title_zh":"SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883601","market":"us","labels":[],"media":"sec.gov","original_id":"AN151316221000027-SPEX","pdf_url":null,"pub_time":1614182400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13D - General statement of acquisition of beneficial ownership","symbol":"SPEX","title":"SC 13D - General statement of acquisition of beneficial ownership","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000151316221000027/0001513162-21-000027-index.htm","us_notice_code":"Form SC 13D","us_title_en":"SC 13D - General statement of acquisition of beneficial ownership","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000151316221000027/sc_13d.htm","primary":true,"translateUrl":null,"linkName":"sc_13d.htm","type":"SC 13D","id":"NTFILEHEjxNVSwNYNG6b1J","market":"us","size":85177}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2021-02-25 00:00","pubTimestamp":1614182400,"title_zh":"SC 13D - General statement of acquisition of beneficial ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883632","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021010360-SPEX","pdf_url":null,"pub_time":1613577600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/0001213900-21-010360-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDED AND RESTATED UNDERWRITING AGREEMENT BY AND BETWEEN THE COMPANY AND H.C.","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ea135980ex1-1_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"ea135980ex1-1_aikidopharma.htm","type":"EX-1.1","id":"NTFILEDr3kKQEYhUd3aVU7","market":"us","size":210347},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ea135980-8k_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea135980-8k_aikidopharma.htm","type":"8-K","id":"NTFILEG7p9a8ecT8ZsiKxf","market":"us","size":29618},{"description":"OPINION OF ELLENOFF GROSSMAN & SCHOLE LLP","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ea135980ex5-1_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea135980ex5-1_aikidopharma.htm","type":"EX-5.1","id":"NTFILE5oFcRtLim85w66AM","market":"us","size":7284},{"description":"FORM OF UNDERWRITER'S WARRANT","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ea135980ex10-1_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea135980ex10-1_aikidopharma.htm","type":"EX-10.1","id":"NTFILE2MXkatVHCfrFvBCs","market":"us","size":103814},{"description":"PRESS RELEASE DATED FEBRUARY 16, 2021","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ea135980ex99-1_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea135980ex99-1_aikidopharma.htm","type":"EX-99.1","id":"NTFILEDT6QB6LSQ5dunAcg","market":"us","size":10750},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ex5-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEDiMeCrJjoixDgESE","market":"us","size":3760},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEC8MuLQuyG6ixd1mc","market":"us","size":5296}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-02-18 00:00","pubTimestamp":1613577600,"title_zh":"8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01項：訂立重要最終協議；第3.02項：未登記出售權益性證券；項目8.01：其他項目；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883616","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021009748-SPEX","pdf_url":null,"pub_time":1613491200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G - Statement of acquisition of beneficial ownership by individuals","symbol":"SPEX","title":"SC 13G - Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021009748/0001213900-21-009748-index.htm","us_notice_code":"Form SC 13G","us_title_en":"SC 13G - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SCHEDULE 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021009748/ea135498-13gaikido_hoththera.htm","primary":true,"translateUrl":null,"linkName":"ea135498-13gaikido_hoththera.htm","type":"SC 13G","id":"NTFILEYbWEbNH3kcPoRNsa","market":"us","size":47708}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2021-02-17 00:00","pubTimestamp":1613491200,"title_zh":"SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883610","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465921023188-SPEX","pdf_url":null,"pub_time":1613404800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","symbol":"SPEX","title":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000110465921023188/0001104659-21-023188-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2021-02-16 00:00","pubTimestamp":1613404800,"title_zh":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883612","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021006449-SPEX","pdf_url":null,"pub_time":1612281600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021006449/0001213900-21-006449-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-02-03 00:00","pubTimestamp":1612281600,"title_zh":"8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01項：訂立重要最終協議；項目8.01：其他項目；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883623","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021004059-SPEX","pdf_url":null,"pub_time":1611504000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021004059/0001213900-21-004059-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE, DATED JANUARY 22, 2021","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021004059/ea133854ex99-1_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"ea133854ex99-1_aikidopharma.htm","type":"EX-99.1","id":"NTFILE8imYnRMsHP3c5QXX","market":"us","size":7776},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021004059/ea133854-8k_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea133854-8k_aikidopharma.htm","type":"8-K","id":"NTFILE5iMd3v3B3rHop5by","market":"us","size":20069},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021004059/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEAPDcGCUW89Mdgo59","market":"us","size":10738}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-01-25 00:00","pubTimestamp":1611504000,"title_zh":"8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"項目8.01：其他項目；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883607","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021002859-SPEX","pdf_url":null,"pub_time":1610985600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021002859/0001213900-21-002859-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021002859/ea133558-8k_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"ea133558-8k_aikidopharma.htm","type":"8-K","id":"NTFILEB2sVx5zWHfA6XoXY","market":"us","size":26683}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-01-19 00:00","pubTimestamp":1610985600,"title_zh":"8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","summary_zh":"項目5.07：將事項提交證券持有人表決","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883595","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021001460-SPEX","pdf_url":null,"pub_time":1610294400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021001460/0001213900-21-001460-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-01-11 00:00","pubTimestamp":1610294400,"title_zh":"8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01項：訂立重要最終協議；第3.02項：未登記出售權益性證券；第5.03項：修改公司章程或章程細則；會計年度的變化；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883615","market":"us","labels":[],"media":"sec.gov","original_id":"AN153561021000028-SPEX","pdf_url":null,"pub_time":1609776000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","symbol":"SPEX","title":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000153561021000028/0001535610-21-000028-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2021-01-05 00:00","pubTimestamp":1609776000,"title_zh":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883625","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020038376-SPEX","pdf_url":null,"pub_time":1605801600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020038376/0001213900-20-038376-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020038376/ea130276ex99-1_alkido.htm","primary":true,"translateUrl":null,"linkName":"ea130276ex99-1_alkido.htm","type":"EX-99.1","id":"NTFILEETiFdX9GjpuUCqvr","market":"us","size":19840},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020038376/ea130276-8k_alkido.htm","primary":false,"translateUrl":null,"linkName":"ea130276-8k_alkido.htm","type":"8-K","id":"NTFILEDu3qVxAAqqkjJQwb","market":"us","size":38995},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020038376/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEGoFgALtso4AQUqPo","market":"us","size":6183}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2020-11-20 00:00","pubTimestamp":1605801600,"title_zh":"8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"項目5.07：將事項提交證券持有人表決；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883614","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020036928-SPEX","pdf_url":null,"pub_time":1605196800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"SPEX","title":"10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度報告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/0001213900-20-036928-index.htm","us_notice_code":"Form 10-Q","us_title_en":"10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":true,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/f10q0920_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"f10q0920_aikidopharma.htm","type":"10-Q","id":"NTFILE6s7XjJmXFxE4cwSi","market":"us","size":469655},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/f10q0920ex31-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10q0920ex31-1_aikido.htm","type":"EX-31.1","id":"NTFILEESjtaLima2zhzsog","market":"us","size":15931},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/f10q0920ex32-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10q0920ex32-1_aikido.htm","type":"EX-32.1","id":"NTFILECsjdozcRnptbQdmf","market":"us","size":6973}],"type_name":"財務報告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"財務報告","earn_infos":[{"id":98442,"name":"Condensed Consolidated Balance Sheets (Unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/R2.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98443,"name":"Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/R3.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98444,"name":"Condensed Consolidated Statements of Operations (Unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/R4.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98445,"name":"Consolidated Statements of Changes in Stockholders' Equity (Unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/R5.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98446,"name":"Condensed Consolidated Statements of Cash Flows (Unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/R6.htm","cdn_url":"","translation_url":"","translate_status":0}],"event_type":"important_notice","event_name":"季度報告","pubTime":"2020-11-13 00:00","pubTimestamp":1605196800,"title_zh":"10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":149,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPEX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-02-01","symbol":"SPEX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1612155600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-11-10","symbol":"SPEX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1604984400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-05-14","symbol":"SPEX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1589428800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2020-03-13","symbol":"SPEX","oldSymbol":"SPEX","newSymbol":"AIKI","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1584072000000},{"market":"US","date":"2020-02-03","symbol":"SPEX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1580706000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPEX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPEX\",market:\"US\",delay:false,,,undefined,":{}}}